Colgate-Palmolive Company

NYSE:CL Stock Report

Market Cap: US$73.9b

Colgate-Palmolive Balance Sheet Health

Financial Health criteria checks 4/6

Colgate-Palmolive has a total shareholder equity of $957.0M and total debt of $8.5B, which brings its debt-to-equity ratio to 887.8%. Its total assets and total liabilities are $16.4B and $15.4B respectively. Colgate-Palmolive's EBIT is $3.9B making its interest coverage ratio 17. It has cash and short-term investments of $1.1B.

Key information

887.8%

Debt to equity ratio

US$8.50b

Debt

Interest coverage ratio17x
CashUS$1.15b
EquityUS$957.00m
Total liabilitiesUS$15.44b
Total assetsUS$16.39b

Recent financial health updates

Recent updates

Colgate-Palmolive's (NYSE:CL) Shareholders Will Receive A Bigger Dividend Than Last Year

Mar 18
Colgate-Palmolive's (NYSE:CL) Shareholders Will Receive A Bigger Dividend Than Last Year

Is Colgate-Palmolive Company (NYSE:CL) Trading At A 33% Discount?

Feb 14
Is Colgate-Palmolive Company (NYSE:CL) Trading At A 33% Discount?

Colgate-Palmolive: I'm Buying Before Interest Rates Decrease

Feb 14

Colgate-Palmolive: Brushing Up Profits In Q4 2023

Jan 30

Is Colgate-Palmolive (NYSE:CL) A Risky Investment?

Jan 19
Is Colgate-Palmolive (NYSE:CL) A Risky Investment?

Getting In Cheap On Colgate-Palmolive Company (NYSE:CL) Might Be Difficult

Jan 01
Getting In Cheap On Colgate-Palmolive Company (NYSE:CL) Might Be Difficult

Colgate-Palmolive: A Better Year Ahead (Rating Upgrade)

Dec 20

Colgate-Palmolive Stock And Its Real Value

Nov 29

Brush Up With Colgate-Palmolive Stock As Earnings Growth Drips On

Nov 14

Colgate-Palmolive (NYSE:CL) Will Want To Turn Around Its Return Trends

Nov 06
Colgate-Palmolive (NYSE:CL) Will Want To Turn Around Its Return Trends

Colgate-Palmolive: Own This Dividend King At The Right Price

Oct 31

Why Colgate-Palmolive Is A Bargain You Shouldn't Ignore Right Now

Oct 13

Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?

Oct 02
Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?

Colgate-Palmolive: Dividend King With Limited Growth

Sep 27

An Intrinsic Calculation For Colgate-Palmolive Company (NYSE:CL) Suggests It's 34% Undervalued

Sep 11
An Intrinsic Calculation For Colgate-Palmolive Company (NYSE:CL) Suggests It's 34% Undervalued

Colgate-Palmolive: Improving Prospects And A Reasonable Valuation

Sep 09

Colgate-Palmolive: A Healthy 7% Return With A Safe Dividend For Investors In A Post-Pandemic World

Aug 16

Colgate And The Importance Of Sales Growth, Expectations Matter

Aug 09

Colgate-Palmolive's (NYSE:CL) Returns On Capital Not Reflecting Well On The Business

Aug 03
Colgate-Palmolive's (NYSE:CL) Returns On Capital Not Reflecting Well On The Business

Colgate-Palmolive: Challenging Growth Prospects

Jul 10

Colgate-Palmolive (NYSE:CL) Is Increasing Its Dividend To $0.48

Jun 27
Colgate-Palmolive (NYSE:CL) Is Increasing Its Dividend To $0.48

Colgate-Palmolive (NYSE:CL) Will Pay A Larger Dividend Than Last Year At $0.48

Jun 13
Colgate-Palmolive (NYSE:CL) Will Pay A Larger Dividend Than Last Year At $0.48

Colgate-Palmolive: The Reasons We Are Becoming More Cautious

Jun 05

Here's Why Colgate-Palmolive (NYSE:CL) Can Manage Its Debt Responsibly

Jun 05
Here's Why Colgate-Palmolive (NYSE:CL) Can Manage Its Debt Responsibly

Calculating The Intrinsic Value Of Colgate-Palmolive Company (NYSE:CL)

May 18
Calculating The Intrinsic Value Of Colgate-Palmolive Company (NYSE:CL)

Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?

Feb 23
Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?

Calculating The Fair Value Of Colgate-Palmolive Company (NYSE:CL)

Feb 05
Calculating The Fair Value Of Colgate-Palmolive Company (NYSE:CL)

What to expect from Colgate-Palmolive's Q4 2022 Earnings

Jan 26

Colgate-Palmolive declares $0.47 dividend

Jan 12

Lorrie Norrington named lead independent director of Colgate

Jan 03

Colgate-Palmolive (NYSE:CL) Will Be Hoping To Turn Its Returns On Capital Around

Jan 01
Colgate-Palmolive (NYSE:CL) Will Be Hoping To Turn Its Returns On Capital Around

Colgate-Palmolive: I Like The Toothpaste But Not The Stock

Dec 22

Colgate-Palmolive: Good Long-Term Prospects But Fairly Valued

Dec 07

Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?

Nov 16
Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?

Colgate-Palmolive Q3 2022 Earnings Preview

Oct 27

Colgate gains on report activist Third Point takes stake

Oct 18

Is Colgate-Palmolive Company (NYSE:CL) Trading At A 45% Discount?

Oct 11
Is Colgate-Palmolive Company (NYSE:CL) Trading At A 45% Discount?

Colgate-Palmolive: 'Boring' Remains Attractive In The Current Market Environment

Sep 29

Colgate-Palmolive's (NYSE:CL) Returns On Capital Not Reflecting Well On The Business

Sep 23
Colgate-Palmolive's (NYSE:CL) Returns On Capital Not Reflecting Well On The Business

Colgate-Palmolive declares $0.47 dividend

Sep 09

CP India names Prabha Narasimhan as MD, CEO

Sep 01

Colgate-Palmolive: What Recent Results Mean For Long-Term Holders

Aug 25

The New 1% Excise Tax On Stock Repurchases Could Impact Companies Such As Colgate- Palmolive

Aug 07

Financial Position Analysis

Short Term Liabilities: CL's short term assets ($5.3B) exceed its short term liabilities ($4.7B).

Long Term Liabilities: CL's short term assets ($5.3B) do not cover its long term liabilities ($10.7B).


Debt to Equity History and Analysis

Debt Level: CL's net debt to equity ratio (768.1%) is considered high.

Reducing Debt: CL's debt to equity ratio has reduced from 3236% to 887.8% over the past 5 years.

Debt Coverage: CL's debt is well covered by operating cash flow (44.1%).

Interest Coverage: CL's interest payments on its debt are well covered by EBIT (17x coverage).


Balance Sheet


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.